Original Research

Published on 24 Jun 2021

SGLT1 Knockdown Attenuates Cardiac Fibroblast Activation in Diabetic Cardiac Fibrosis

in Cardiovascular and Smooth Muscle Pharmacology

Hui Lin
Le Guan
Liping Meng
Hiroyasu Uzui
Hangyuan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.700366

4,189 views
16 citations

Original Research

Published on 24 Jun 2021

Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling

in Cardiovascular and Smooth Muscle Pharmacology

Zaixiong Ji
Jiaqi Li
Jianbo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.672150

4,571 views
11 citations

Original Research

Published on 22 Jun 2021

Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus

in Cardiovascular and Smooth Muscle Pharmacology

Angela Sciacqua
Francesco Andreozzi
Elena Succurro
Daniele Pastori
Vittoria Cammisotto
Giuseppe Armentaro
Gaia C. Mannino
Teresa Vanessa Fiorentino
Pasquale Pignatelli
Dominick J. Angiolillo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.695961

3,711 views
11 citations

Original Research

Published on 22 Jun 2021

Ivabradine Ameliorates Cardiac Diastolic Dysfunction in Diabetic Mice Independent of Heart Rate Reduction

in Cardiovascular and Smooth Muscle Pharmacology

Hao Xie
Xing-Yi Shen
Na Zhao
Peng Ye
Zhen Ge
Zuo-Ying Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.696635

2,911 views
1 citation

Review

Published on 22 Jun 2021

Regional Heterogeneity of Perivascular Adipose Tissue: Morphology, Origin, and Secretome

in Cardiovascular and Smooth Muscle Pharmacology

Xinzhi Li
Zhongyuan Ma
Yi Zhun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.697720

6,913 views
35 citations

Original Research

Published on 18 Jun 2021

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

in Cardiovascular and Smooth Muscle Pharmacology

Xiaoye Li
Xiaochun Zhang
Qinchun Jin
Ying Xue
Wenjing Lu
Junbo Ge
Daxin Zhou
Qianzhou Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2021.614762

4,145 views
10 citations

Review

Published on 17 Jun 2021

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

in Cardiovascular and Smooth Muscle Pharmacology

M. Ekholm
T. Kahan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.640185

7,405 views
29 citations

Review

Published on 16 Jun 2021

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids

in Cardiovascular and Smooth Muscle Pharmacology

Qinyu Li
Bing Gao
Bateer Siqin
Qian He
Ru Zhang
Xiangxi Meng
Naiheng Zhang
Na Zhang
Minhui Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.651926

7,222 views
23 citations

Original Research

Published on 15 Jun 2021

Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction Model

in Cardiovascular and Smooth Muscle Pharmacology

Marian Wesseling
Eva Mulder
Maike A. D. Brans
Daniek. M. C. Kapteijn
Marian Bulthuis
Gerard Pasterkamp
Marianne C. Verhaar
A. H. Jan Danser
Harry van Goor
Jaap A. Joles

Frontiers in Pharmacology

doi 10.3389/fphar.2021.614656

5,947 views
3 citations

Original Research

Published on 14 Jun 2021

Serum Metabolomic Analysis of Coronary Heart Disease Patients with Stable Angina Pectoris Subtyped by Traditional Chinese Medicine Diagnostics Reveals Biomarkers Relevant to Personalized Treatments

in Cardiovascular and Smooth Muscle Pharmacology

Na Guo
Peili Wang
Jiaying Yang
Xiaofang Yang
Monique van der Voet
Marjolein Wildwater
Junying Wei
Xuan Tang
Mei Wang
Hongjun Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.664320

5,688 views
9 citations

Original Research

Published on 14 Jun 2021

Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway

in Cardiovascular and Smooth Muscle Pharmacology

Zhiwei Zhang
Xiaowei Zhang
Lei Meng
Mengqi Gong
Jian Li
Wen Shi
Jiuchun Qiu
Yajuan Yang
Jianping Zhao
Ya Suo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.658362

9,457 views
63 citations

Original Research

Published on 14 Jun 2021

Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways

in Cardiovascular and Smooth Muscle Pharmacology

Jia-jia Xu
Run-jing Li
Zheng-hao Zhang
Cui Yang
Shi-xiao Liu
Yan-ling Li
Min-wei Chen
Wei-wei Wang
Gong-ye Zhang
Gang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2021.678886

6,089 views
23 citations

Original Research

Published on 10 Jun 2021

Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction

in Cardiovascular and Smooth Muscle Pharmacology

Liyun Zhang
Juan Chen
Lianhua Yan
Qin He
Han Xie
Manhua Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.646240

10,665 views
33 citations

Original Research

Published on 09 Jun 2021

Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development

in Cardiovascular and Smooth Muscle Pharmacology

Na Wang
Sha Qiu
Ya Yang
Chi Zhang
Zhi-Chun Gu
Yan Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2021.673302

3,040 views
8 citations

Original Research

Published on 08 Jun 2021

DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation

in Cardiovascular and Smooth Muscle Pharmacology

Bingjiang Han
Jiajun Xu
Xiaowen Shi
Zhanxiong Zheng
Fengjie Shi
Fenfen Jiang
Jibo Han

Frontiers in Pharmacology

doi 10.3389/fphar.2021.688140

2,798 views
16 citations

Original Research

Published on 07 Jun 2021

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice

in Cardiovascular and Smooth Muscle Pharmacology

Urszula Tyrankiewicz
Mariola Olkowicz
Piotr Berkowicz
Magdalena Jablonska
Ryszard T. Smolenski
Jerzy A. Zoladz
Stefan Chlopicki

Frontiers in Pharmacology

doi 10.3389/fphar.2021.682432

3,330 views
7 citations

Navigation group

Articles

SGLT1 Knockdown Attenuates Cardiac Fibroblast Activation in Diabetic Cardiac Fibrosis

Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling

Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus

Ivabradine Ameliorates Cardiac Diastolic Dysfunction in Diabetic Mice Independent of Heart Rate Reduction

Regional Heterogeneity of Perivascular Adipose Tissue: Morphology, Origin, and Secretome

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids

Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction Model

Serum Metabolomic Analysis of Coronary Heart Disease Patients with Stable Angina Pectoris Subtyped by Traditional Chinese Medicine Diagnostics Reveals Biomarkers Relevant to Personalized Treatments

Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway

Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways

Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction

Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development

DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice